| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001553A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001551A1 Tyrosine kinase associated protein-1 (tka-1), nucleotide and amino acid sequences and their use in diagnosis and treatment of tka-1 related disorders |
| 01/15/1998 | WO1998001550A2 Vaccine against gastro-intestinal nematodes |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001548A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | WO1998001542A1 Human telomerase |
| 01/15/1998 | WO1998001541A1 Traf2-associated protein kinase and assays |
| 01/15/1998 | WO1998001538A1 Method of activating dendritic cells |
| 01/15/1998 | WO1998001535A1 Method for the production of polypeptides |
| 01/15/1998 | WO1998001534A1 Novel methods and compositions for combinatorial-based discovery of new multimeric molecules |
| 01/15/1998 | WO1998001475A1 Growth factor receptor-binding insulin receptor |
| 01/15/1998 | WO1998001474A2 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 01/15/1998 | WO1998001473A1 Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
| 01/15/1998 | WO1998001472A1 Fluorescent peptides |
| 01/15/1998 | WO1998001471A1 Methods for determining the presence of brain protein s-100 |
| 01/15/1998 | WO1998001470A1 A transcription factor |
| 01/15/1998 | WO1998001469A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001468A1 Chondrocyte proteins |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001466A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001463A1 Nucleic acid encoding vertebrate cdc37 |
| 01/15/1998 | WO1998001462A2 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001158A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | WO1998001155A1 Compositions and methods for regulating hiv gene expression |
| 01/15/1998 | WO1998001154A2 Treatment and diagnosis of infections of gram positive cocci |
| 01/15/1998 | WO1998001153A1 Medicinal compositions for extracorporeal blood circulation circuit and method for inhibiting blood coagulation in extracorporeal blood circulation circuit |
| 01/15/1998 | WO1998001149A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | WO1997034926A3 Bacillus thuringiensis genes encoding nematode-active toxins |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | DE19628705A1 Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe New oxygen transfer agent containing them hemoglobin-hydroxyethylstarch conjugates, processes for their preparation, and to their use as blood substitutes |
| 01/15/1998 | DE19628236A1 Reagenz zur Erhöhung der Serinproteasen-Inhibitionsspezifität Reagent to increase the serine protease Inhibitionsspezifität |
| 01/15/1998 | CA2263098A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
| 01/15/1998 | CA2260368A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | CA2260360A1 Use of a panel of heterokaryons to produce variants of multimeric proteins |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260293A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259965A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | CA2259961A1 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259416A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |
| 01/15/1998 | CA2259413A1 Methods for determining the presence of brain protein s-100 |
| 01/15/1998 | CA2259157A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2258947A1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | CA2210520A1 Homologous recombination for animal model exhibiting reduced levels or elimination of a neuronal intermediate filament |
| 01/14/1998 | EP0818536A1 Dna molecule relating to suppression of gene expression and novel protein |
| 01/14/1998 | EP0818535A1 Novel yeast genes |
| 01/14/1998 | EP0818534A1 Human Interleukin 12 gene expression regulating sequences |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818467A2 Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same |
| 01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
| 01/14/1998 | EP0818465A1 Genomic sequence of Rhizobium sp. NGR234 symbiotic plasmid |
| 01/14/1998 | EP0818204A2 Stabilized albumin-free recombinant factor VIII preparation having a low sugar contant |
| 01/14/1998 | EP0817969A1 Inhibition of tau-tau-association |
| 01/14/1998 | EP0817865A1 Method for diagnosis of epstein-barr virus associated disease |
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817854A2 Antigen presentation system based on retrovirus-like particles |
| 01/14/1998 | EP0817853A1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817850A1 Plant pathogen resistance genes and uses thereof |
| 01/14/1998 | EP0817849A1 Genetic sequences conferring nematode resistance in plants and uses therefor |
| 01/14/1998 | EP0817848A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817842A1 Antibody to human betacellulin and use thereof |
| 01/14/1998 | EP0817817A1 Novel ice-controlling molecules and their applications |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817799A1 Plasmid vaccine for pseudorabies virus |
| 01/14/1998 | EP0817798A1 Nucleotide and protein sequences of lats genes and methods based thereon |
| 01/14/1998 | EP0817792A1 Compositions for the diagnosis, prevention, and treatment of tumor progression |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817778A1 Reversible protease inhibitors |
| 01/14/1998 | EP0817649A1 Limbic system-associated membrane protein and dna |
| 01/14/1998 | EP0817647A1 Treatment for verotoxin-producing escherichia coli |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817614A1 Stable protein:phospholipid compositions and methods------------ |
| 01/14/1998 | EP0784425A4 Gene controlling floral development and apical dominance in plants |
| 01/14/1998 | EP0667916B1 Crf binding protein |
| 01/14/1998 | EP0661987B1 Morphogen-induced liver regeneration |
| 01/14/1998 | EP0659276B1 Immunoassay for detecting collagen or collagen fragments |
| 01/14/1998 | EP0500799B1 Particle mediated transformation of animal skin tissue cells |
| 01/14/1998 | EP0429570B1 Osteoinductive compositions |
| 01/14/1998 | EP0379556B1 Production of glucose oxidase in recombinant systems |